Your browser doesn't support javascript.
loading
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
Schischlik, Fiorella; Jäger, Roland; Rosebrock, Felix; Hug, Eva; Schuster, Michael; Holly, Raimund; Fuchs, Elisabeth; Milosevic Feenstra, Jelena D; Bogner, Edith; Gisslinger, Bettina; Schalling, Martin; Rumi, Elisa; Pietra, Daniela; Fischer, Gottfried; Faé, Ingrid; Vulliard, Loan; Menche, Jörg; Haferlach, Torsten; Meggendorfer, Manja; Stengel, Anna; Bock, Christoph; Cazzola, Mario; Gisslinger, Heinz; Kralovics, Robert.
Afiliação
  • Schischlik F; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Jäger R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Rosebrock F; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Hug E; MyeloPro Diagnostics and Research, Vienna, Austria.
  • Schuster M; MyeloPro Diagnostics and Research, Vienna, Austria.
  • Holly R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Fuchs E; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Milosevic Feenstra JD; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Bogner E; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Gisslinger B; Ludwig Boltzmann Institute for Hematology and Oncology and.
  • Schalling M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Rumi E; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Pietra D; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Fischer G; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Faé I; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Vulliard L; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Menche J; Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria; and.
  • Haferlach T; Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria; and.
  • Meggendorfer M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Stengel A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Bock C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Cazzola M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Gisslinger H; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Kralovics R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Blood ; 134(2): 199-210, 2019 07 11.
Article em En | MEDLINE | ID: mdl-31064751
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Áustria